Message from the Committee ChairmenOn behalf of the Forrest General Hospital Cancer Committee, we are glad to present our 2006 Cancer Program Annual Report. The reportconsists of a summary of the dedicated efforts made by the Cancer Committee, Cancer Registry, Administration, Physicians, and Cancer TeamMembers.__________________________Joseph Salloum, MDNagen Bellare, MDMessage from the Cancer LiaisonThe Cancer Committee’s responsibility is to plan, initiate, encourage, and monitor cancer team activities. The Goals for 2006 include:Clinical Goal – National Colorectal Cancer Awareness, National Skin Cancer Awareness, National Prostate Cancer Awareness, National BreastCancer Awareness, and National Lung Cancer Awareness; Community Outreach – Increase community awareness and participation inprevention and early detection activities; Publish and distribute the Cancer Program Annual Report; Professional Education and StaffSupport – Enhance staff education by attending the MS Cancer Registrar Association (MCRA) Conference and National Cancer RegistrarAssociation (NCRA) Conference; and Programmatic – Collaborate with Cancer Team members and colleagues to accomplish the goals andinitiatives for 2006. Quality Improvements – Studies of Quality and Outcomes: (Standard 8.1) I. Brain and CNS Tumor Study:Glioblastoma Multiforme, II. Prostate Treatment: Surgery versus Radiation Therapy 2000 versus 2005, III. Monitor attendance at cancerconference and form initiatives to increase attendance; Patient Care Improvement (Standard 8.2) I. Initiatives to improve the outpatientchemotherapy scheduling for the Oncology Unit, II. Awareness campaign to inform physicians that patient’s with early-stage breast cancer,Lumpectomy with Radiation Therapy is recommended as the standard of care, and III. Is there a decrease in colorectal cancer in overallcases and a shift to earlier stage since colonoscopy was approved by Medicare in July 2001?__________________________William Woods, MD
Services and ActivitiesPatient Satisfaction: 99th Percentile Forrest General Salutes Cancer Survivors at National Hospice Month 1st in South MSComputerizedfor the Cancer Center Southern Miss Homecoming game PhysicianOrder Entry System1st Signa EXCITE High Pain Management at Lincoln Center Groundbreaking on the NCR Week“Cancer Registrars…Definition 3Tesla MRI in MS FGH Pine Grove Psychology Services 28th Place Women’s Center Advocates inAction”American Cancer Society Employee Health Challenge: First Annual Spirit of Women Waiting for aCure: CelebrityRelay for Life Quit Smoking Symposium WaiterAmerican Cancer Society Awards: Physician Volunteer of the Year MS Health Initiatives Volunteer of the Year Nagen Bellare, MD Cherri Marshall, Director Cancer CenterQuality of Life Awards: Morris Conoly, Clinical Specialist-7T CherriMarshall, Director Cancer Center Michelle Williams, Clinical Speicialist-6TThe Pink Ribbon Fund’s Second First Annual Hope Conference “Tickle Me Pink” BCAT 2nd annualAnnual “Legacy of Love” Luncheon breast cancer awareness programSkin Cancer Detection and The Waiting for a Cure Fund, FGH, When They Rely on You Camp BluebirdDonation
Prevention Month Hattiesburg Clinic Cancer Survivors Picnic Workshop for caregivers by TelephonePioneersForrest General Hospital New Outpatient Evaluation Center AJCC Staging Forms “The Pink Palate”CookbookCommunity Value 5-Star Hospitalto West Hattiesburg Online in Misys Spirit of Women andWaiting for a Cure FundKarnes Center student’s tourForrest General Hospital Cancer CenterLatest Technology Innovations
Oncology Team(Picture of Dr) N. Joseph Salloum, MD (Picture of Dr ) Nagen Bellare, MD FGH Cancer Center Hattiesburg Clinic, P.A. Medical School: University of Cairo (Egypt) Medical School: Bangalore Medical College (India) Internship: Cairo University Hospital Internship: (IM) Northwestern University School of Medicine Residency: (IM and RO) New York Methodist Hospital Residency: (IM) Northwestern University School of Medicine Fellowship: (Hematology/Oncology) Cook CountyHospital (Chicago) and M.D. Anderson Cancer Center (Houston)(Picture of Dr ) Alphonso Willis, MD (Picture of Dr) Lisa K. Bond, MD Hattiesburg Clinic, P.A. Hattiesburg Clinic, P.A. Medical School: Harvard University Medical School: University of MS School of Medicine Internship: Letterman Army Medical Center (Calif.) Internship: (IM) UMC (Jackson) Residency: Letterman Army Medical Center (Calif.) Residency: (IM) UMC; (Radiology) UMC Fellowship: (Oncology) Letterman Army Medical Center (Calif.) Fellowship: (Hematology/Oncology) UMC(Picture of Dr) William K. Woods, MD (Picture of Dr) J. Michael Herrington, MD
FGH Cancer Center Hattiesburg Clinic, P.A.Medical School: Albert Einstein College of Medicine Medical School: University of MS School ofMedicineInternship: (IM) Englewood Hospital and Medical Center Internship: (IM) UMCResidency: (RT) University of California Residency: (IM) UMC Fellowship: (Hematology/Oncology) UMC
Oncology Team(Picture of Dr) Mei-Chang “Mike” Cheng, MD (Picture of Dr) Glenn N. Smith, MD FGH Cancer Center The Hematology and Oncology Clinic Medical School: St. George’s University School of Medicine Medical School: University of MSSchool of Medicine Internship: (General Surgery) Maimonides Medical Center, NY Internship: UMC Residency: (RT) New York Methodist Hospital, NY Residency: UMC Fellowship: (General Surgery)Maimonides Medical Center, NY(Picture of Dr) Harry L. Butler, MD The Hematology and Oncology Clinic Medical School: University of MS School of Medicine Internship: Medical College of Georgia Residency: Medical College of Georgia Fellowship: (Hematology/Oncology) UMC
Music Therapy: Keep a Song in Your Heart Music Therapy roots started not with cancer patients, or patients with life threatening diseases, but music as therapy hasbeen around since the days of Plato. In the 20th century, it was established after World War I and II for soldiers suffering frombattle induced stress and trauma. Today, Music Therapy is an established healthcare profession that uses music to soothe thephysical, emotional, cognitive, and social needs of people. Music Therapy can be used to improve ones life whether healthy,disabled, or ill. Music Therapy interventions include: promote wellness, manage stress, alleviate pain, express feelings, enhancememory, improve communication, and promote physical rehabilitation. Music therapists perform an assessment of the patient. What are the patient’s emotional well-being, physical health,social functioning, communication abilities, and cognitive skills through musical responses? They design music sessions forindividuals and groups based on client needs using music improvisation, receptive music listening, song writing, lyricdiscussion, music and imagery, music performance, and learning through music. The music therapist partakes ininterdisciplinary treatment planning, ongoing evaluation, and follow up. Persons who complete an approved college musictherapy curricula and internship are eligible to sit for the national examination offered by the Certification Board for MusicTherapists. Patients with mental health needs, Alzheimer’s disease, substance abuse problems, brain injuries, physical disabilities,and/or acute and chronic pain can benefit from music therapy. At New York’s Memorial Sloan-Kettering Cancer Center, thepatients who were visited by a trained music therapist reported less anxiety and better overall mood than patients who did notreceive music therapy (Cancer Vol. 98, No. 12: 2723-2729). Studies suggest that music does trigger physical responses,including:
Reducing blood pressure, heart rate and breathing Increasing feelings of self-worth and easing depression Decreasing one’s perception of pain Occupying neurotransmitters that would otherwise be used to transmit pain messages to the brain Reducing levels of stress, anxiety and fear “Good music touches us in depths we didn’t even know we had. In this way it is tied to ourgrowthand evolution, both emotionally and spiritually.” Stanley Jordan, Jazz guitarist.
Forrest General Cancer Services Photo of MS 2005 Cases per county The individual patient and their family remain the focus of the Forrest General Hospital cancer services. State-of-the-art treatmentsand support services are delivered in comfortable surroundings utilizing an interdisciplinary approach that involves the individual, family,friends and health care professionals. Surgery has an important role in diagnosing and staging (finding the extent) of cancer. Advances in surgical techniques have allowedsurgeons to successfully operate on a growing number of patients. Today, more limited (less invasive) operations are often done to removetumors while preserving as much normal function as possible. Radiation Therapy: Forrest Generals Radiation Oncology Department was opened in 1967, when Forrest General became the first areahospital to offer cobalt therapy. Since that time, Radiation Oncology has maintained its leadership role. Currently, the center is equippedwith two state of the art Varian Linear Accelerators with 120 multi leaf collimators that can offer patient 3-D conformal and IntensityModulated radiation therapy. The center also offers prostate brachytherapy, Mammosite for partial breast radiation, High Dose RateBrachytherapy, systemic isotope therapy, and radioimmunotherapy. Chemotherapy/Biotherapy: Forrest General Hospital and the Medical Oncologists have taken great pride in providing up-to-datechemotherapy protocols for treating cancer. Currently, there are numerous clinical research protocols funded by the National CancerInstitute. These new treatment protocols for breast, colorectal, lung, pancreatic, multiple myeloma, kidney, and prostate cancer as well asvarious other blood and soft tissue malignancies are available. For more information regarding chemotherapy/biotherapy, please callTammy McBeth, RN, FGH Cancer Center Research Coordinator (601) 288-8289.
Camp Bluebird sponsored by Forrest General Hospital was the first camp in South Mississippi designed for adults with a cancerdiagnosis. The two-and-a-half-day camp is held at Paul B. Johnson State Park and includes optional recreational activities, social events,devotionals, education opportunities and lots of sharing time. The camps purpose is to promote a sense of well-being among campers, toteach skills for living with cancer and cancer treatments, and to provide a time for rest and relaxation. Witness Project: The program is designed to reach African-American women throughout South Mississippi. The program features agroup of African-American women who "witness" about their triumph over breast or cervical cancer. Together, these women proclaim thegood news that cancer does not have to be a terminal illness. The programs purpose is to reach female segments within the population whomay be unaware of the warning signs and uninformed about prevention and treatment. Through early detection and treatment, women canoften have their cancer cured. Breast self-exam is taught by trained health instructors using special breast-shaped models. Audiences canlearn first-hand how best to perform periodic checks to detect lumps and other signs of cancer. Instructors also inform groups about otherprevention methods like Pap tests, a test to find cervical cancer, and mammograms, an imaging procedure designed exclusively to detectbreast cancer. Participants also learn where to obtain preventive tests at the lowest possible cost. The Tree of Life is a sculpture affixed to the wall of the main lobby of the Forrest General Cancer Center. The tree bears the names ofthose who make donations used to promote activities that heighten cancer awareness. Individual donations can commemorate a happyoccasion, a celebration of friends or family, an expression of sympathy or can be made in memory of another individual. The Tree of Liferesembles South Mississippis native pine tree. The cherry and mahogany figure was hand-carved by artist Sanford Werfel of North Brunswick,New Jersey. Designed with pine needle clusters, pine cones, service vignettes and stones, the trunk bears the Forrest General name and logo. Reach to Recovery: Forrest GeneralHospital and the American Cancer Society havejoined forces in offering Reach to Recovery, arehabilitation program for women who havehad breast cancer. The program is designed to helpwomen meet the physical, emotional and cosmeticneeds related to their disease and treatment.Women who have experienced breast cancer serveas volunteers to help other women facing thedisease. Medical Social Services is an important link between patient, family, medical team, and community. Medical Social Services personnelhelp with discharge planning, patient and family counseling, and serve as a liaison to community services.
Hospice utilizes an interdisciplinary team approach to offer support and compassionate care for terminally ill patients and theirfamilies. Patients who are no longer under treatment for cure may be referred to the program by their physician, family, friends, clergy orother health care professionals. A family member or friend must be available as the primary caregiver, and the personal physician must agreeto hospice care. Hospice regards dying as a normal process and provides patients and their family’s psychological, social, spiritual andvolunteer support. Patients also receive appropriate medical care so they can remain as alert and pain-free as possible. Hospice encouragesfamilies and caregivers to continue with their routines and extends support for a year following the patients death. Home Care: When a loved one becomes ill or is injured and requires intermittent health care, Forrest General Home Care can provideflexibility to families. Home Care provides dependable, specially-trained nurses, nursing assistants, and therapists to ease the familysresponsibilities. Cost-effective Home Care services allow patients to enjoy the familiarity and comfort of their home instead of a hospital ornursing home room. The following services are provided for people of all ages: newborns to seniors: Skilled Nursing Care, Ostomy/WoundNursing Services, Personal Care Services, Physical Therapy, Occupational Therapy, Speech Therapy, Medical Social Services, Psych/MentalHealth Nursing Services, Intravenous (IV) Therapy and Pediatric Services. Dietitians: Specially trained cancer patient dietitians assist the medical team in the assessment of the patients nutritional status,alternate or supplemental feeding methods and assurance of adequate oral intake and calorie count. Nutritional consultation also is availableto outpatients upon request. Pastoral Services provides pastoral visitation and counseling for all patients requesting its services. Hospitalization provides time forreflection, which often brings forth hopes and fears. This reflection is normal and can be a time for spiritual growth. The Chaplain and otherPastoral Services staff are dedicated to helping patients and their families toward the fullest possible recovery. Spiritual resources, includingForrest Generals devotional opportunities, can be an effective aid during a patients healing process. Several local and state church servicesare available through patient room television sets. Pastoral Services also facilitates pastoral ministries of area clergy through contemporaryhealth care training programs, education and individual consultations. For more information about Forrest General Cancer Services, please call FGH OnCall at 1-800-844-4445.
Brain and CNS Tumors: Glioblastoma Multiforme Treatment Options and StatisticsA variety of tumor types originate in the brain and spinal cord (CNS). In 2006, the American Cancer Society estimates that 18,820 malignanttumors of the CNS will be diagnosed in the United States (10,730 in men and 8,090 in women).Brain and CNS TumorsThe Forrest General Hospital Cancer Registry has accessioned a total of 667 primary brain FGH Incidence of Primary Brain and CNS and CNS tumors from Tumors FG 2001-2005 1968 to December 2004. CBTRU H 31 32 The FGH Incidence of 35 29 27 S N: N: 30 24 Primary Brain and CNS 25 # of Cases ICDO 58,90 16 20 Tumors graph 2001-2005 Code Primary Site 7 3 15 cases: 2001 = 29, 2002 10 Frontal, temporal, 5 = 24, 2003 = 31, 2004 = 0 C71.1- parietal, and occipital 20 20 20 20 20 27, and 2005 = 32. The 01 02 03 04 05 C71.4 lobes of the brain 31% 38% Central Brain Tumor Years C71.0 Cerebrum 3% 2% Registry of the United States compared with FGH is displayed in the graph C71.5 Ventricle 1% 1% below. The graph reveals similar distribution: 31% CBTRUS and 38% FGH C71.6 Cerebellum 4% 3% for lobes of the brain, 24% CBTRUS and 26% FGH for the meninges, and FGH C71.7 Brain Stem 2% 2% higher for pituitary tumors at 10% and CBTRUS at 7%. C71.8- C71.9 Other Brain 16% 12% C72.0- Spinal cord and cauda C72.1 equina 4% 4% C72.8- C72.9 Other nervous system 1% 1% C70.0- Meninges (cerebral & C70.9 spinal) 24% 26% C75.1- C75.2 Pituitary 7% 10%
Glioblastoma Multiforme (GBM), also known as a Grade IV Astrocytoma, is the most common type of primary brain tumor occurring in adults.GBM comprise of 52 percent of all primary brain tumors and 20 percent of all intracranial tumors. The occurrence rate is 2-3 per 100,000population in Europe and North America. Diagnosis is made by analysis of tissue removed at biopsy or cyto-reductive surgery. Treatmentoptions include: surgery, radiation, and chemotherapy. Radiation therapy is the most effective. However, all are essentially palliative; fiveyear survival remains unchanged for over thirty years at less than five (5) percent. Tumor spread is generally by direct extension from theinitial area of involvement. Metastasis outside the CNS is exceedingly rarealthough discontinuous spread within the CNS occurs in up to 10 percent of patients.
Brain and CNS Tumors: Glioblastoma Multiforme Treatment Options and Statistics CBTRUS Histology FGH Histology 1997-2001 1997-2001 13% 10% 11% 5% 10% Astrocytoma Astrocytoma Glioblastoma 4% Glioblastoma 6% Oligodendroglioma Oligodendroglioma 21% Meningioma 3% 4% 29% Meningioma Lymphoma Lymphoma 3% Gliomas Gliomas 4% Pituitary Pituitary Others 2% Others 30% 40% Recurrence following treatment is virtually inevitable, usually at or near the FGH GLIOBLASTOMA Initial Therapy original site. Salvage therapy via repeat surgery, radiation therapy and/or Analytical Cases 1997-2001 chemotherapy may be attempted but the benefit of various strategies remains SRG RAD CHM N: 44 13.6% RAD CHEMO uncertain. The prognosis for patients with GBM is grim. Median survival without 11.4% treatment of any kind is approximately three (3) months. Five year survival with NO TREATMENT aggressive therapy is less than five (5) percent. Death usually results from 9.1% progressive loss of CNS function or complications developing from loss of CNS RAD25.0% function (ie.: sepsis, venous thrombo-embolism). ALL OTHER 4.5% Glioblastoma Multiforme One-, Two-, Three-, Four-, Five-, and Ten-Year Relative SRG RAD Survival 1973-2001 36.4% # of 1- 2- 3- 4- 5- 10- Cases Yr Yr Yr Yr Yr Yr CBTRUS 15,098 29.1 8.8 5.2 4 3.4 2.4 FGH 167 27.1 6 3 3 3 2
Michael L. Goodman, MD
Prostate CancerTreatment Options and StatisticsReview of Cases 2000, 2005 Early StageProstate Cancer Early Stage Treatment ComparisonFive-Year Relative Survival Comparison FGH versus ACSFor 2006, the American Cancer Society estimates 234,460 men will be diagnosed with prostate cancer in the United States. Prostate Canceris the most frequently diagnosed cancer in men. Incidence rates are significantly higher in African American men than in Caucasian men.About 27,350 men will die from the disease this year. While one man in six will get prostate cancer during his lifetime, only one in 34 will dieof this disease.This data of Early Stage Prostate Cancer 2000 versus 2005 includes 90 cases and 116 respectively.
Prostate Cancer Early Stage 2000 Prostate Cancer Early Stage 2005 By Age at Diagnosis By Age at Diagnosis Analytical Cases Analytical Cases N: 90 40 N: 116 39 40 40 40 35 34 35 30 PERCENT OF CASES 30 PERCENT OF CASES 25 25 20 17 18 20 15 15 10 9 10 5 3 1 5 0 50-59 60-69 70-79 80-89 90+ 0 50-59 60-69 70-79 80-89 AGE DISTRIBUTION AGE DISTRIBUTIONProstate Cancer Early Stage Treatment Comparison
Prostate Cancer Early Stage 2000 Prostate Cancer Early Stage 2005 Surgery vs. Radiation Therapy Surgery vs Radiation Therapy Analytical Cases Analytical Cases N: 86 N: 115 70% 65% Percentage of Cases 60% 70% 63% Percentage of Cases 50% 60% 50% 40% 40% 30% 30% 17% 20% 12% 14% 20% 12% 7% 6% 10% 2% 10% 2% 0% 0% y T RT t T P ap os y T R t P R os R ap R m er R Pr ed TU m ed Pr er TU ea th in ea ad th n y lB ad b lB bi ch R hy om R na om ra na c C ra er B C er B xt xt E ENote: Prostate Cancer Early Stage 2000: 4 pts excluded due to no surgery or radiation therapy.Prostate Cancer Early Stage 2005: 1 excluded no tx, recommended brachytherapy; downsizing prostate gland. Prostate Brachytherapy Brachytherapy of the prostate is the process of implanting radioactive seeds directly into the prostate gland. Radiation is achieved by use of either Iodine I-125 or Palladium Pd-103; approximately 60-150 seeds are used depending on the individual patient. The intent is to deliver radiation to a confined volume while sparing much of the adjacent normal tissue (such as bladder and rectum). Brachytherapy is for early-stage, organ confined cancer. SurvivalThe Five-year relative survival rates for patients whose tumors are diagnosed at an early stage are 100% for FGH and AmericanCancer Society.
Distribution by County Prostate Cancer Early Stage 2000 Prostate Cancer Early Stage 2005 Distribution by County Distribution by County Analytical Cases Analytical Cases N: 116 MS-JONES N: 90 MS-JONES MS-MARION 10.3% MS-STONE 16.7% 10.0% 9.5% MS-WALTHALL MS-WALTHALL 7.8% 7.8% MS-FORREST 26.7% MS-FORREST MS-MARION MS-LAMAR 20.0% 6.9% 6.7% ALL OTHER ALL OTHER 38.8% 38.9%ConclusionsPermanent prostate brachytherapy has emerged as a definitive treatment option in men with clinically localized prostate cancer.It represents the ultimate 3-D conformal therapy, permitting dose escalation far exceeding other radiation modalities. Theresurgence of interest in brachytherapy was principally due to the evolution of transrectal ultrasonography, the development of aclosed transperineal approach and advanced treatment planning software.Biochemical control rates in patients treated with brachytherapy appear similar to those in patients treated with radicalprostatectomy or external beam radiation. We have performed close to 500 prostate seed implants since we began ourbrachytherapy program in 2001.Joseph Salloum, MD
Primary Site Table 2005 (Analytical 839, Non-Analytical 158)Primary site Number of Cases Percent Primary Site Number ofCases PercentOral Cavity & Pharynx 39 4% Female Genital Organs34 3% Mouth 5 Cervix Uteri 10 Pharynx 5 Corpus Uteri 9 Tongue 8 Ovary 9 Other Oral 21 Vagina/Vulva 6Digestive System 142 14% Breast 164 16% Esophagus 10 Stomach 11 Male Genital Organs 17618% Small Intestine 2 Prostate 175 Colon 60 Testis 1 Rectum 21 Liver/Biliary 12 Urinary Tract 35 4% Pancreas 19 Bladder 9 Other 7 Kidney 23 Other 3
Respiratory System 213 21% Brain/CNS 354% Larynx 12 Lung 199 Endocrine 232% Other 2Bone/Connective Tissue 9 1% Lymphatics/Hematopoietic77 8%Skin – Melanomas 19 2% Skin – Other4 .40%All Others 27 3% Cancer Registry The Cancer Registry is the cornerstone of the cancer program at Forrest General Hospital. The registry abides bythe standards set by the American College of Surgeons Commission on Cancer and the Cancer Committee. The objectiveof the registry is to guarantee accurate and timely collection of diagnosed and/or treated cancerpatient data since 1968, which allow for the evaluation of patient outcomes and identification ofopportunities for improvement. Lifetime follow- up of patients included in the database supportsclinical follow- up and surveillance of additional primaries. Registry activities in 2005 included 14data requests from physicians, administration, and other departments, and coordination anddistribution of the 2005 Cancer Program of Excellence Annual Report. The Cancer Registry Staff
Members are Daphne Nix, BS, CTR, Cancer Registrar; Jena Hopkins, Cancer Registrar; and Juliet Hinton, BSB, MBA, CTR,Cancer Registry Manager. FGH Cancer Cases 2005Summary of Cases Analytic/Non-analytic N: Analytic = 839 Non-Analytic = 158 84 90 There were 997 cases added to the registry in 80 2005, 839 analytic PERCENT OF CASES 70cases diagnosed and/or treated and 158 non-analytic 60 cases seen at 50Forrest General Hospital. Review of 2005 primary sites 40 for Forrest General 16reveals lung as the most common site with 199 cases (20%). The other 30 20top sites include prostate 175 cases (16%), breast 164 cases (16%), and 10 0 2005colorectal 85 cases (8%). ACCESSION YEAR ANALYTIC NON-ANALYTICCancer Conference Cancer Conference is held weekly on Tuesday and offers multidisciplinary consultative services for patients. The Conferences also offer education to physicians and allied health professionals. In 2005, 124 cases were discussed at conference. Eighty- one percent were prospective cases. The leading sites included breast, lung, colorectal, head and neck, and lymphoma. Forrest General Hospital is accredited by the MS State Medical Association to provide continuing medical education (CME) for physicians in this educational activity for one credit towards the AMA Physician’s Recognition Award. For more Cancer Conference information,please contact the Cancer Registry at (601) 288-2914.
Physicians Presenting at Cancer Conference 2005 Ralph Abraham, MD Nagen Bellare, MD Sean Fink, MD KevinBlanchard, MD Mike Cheng, MD Milam Cotten, MD Howell Crawford, MD James Duncan, MD Scott Guidry, MD Alan Greenwald, MD William Gullung, III, MD Michael Hammett,MD Michael Lowry, MD Charles Parkman, MD Richard Pecunia, MD JosephSalloum, MD John Sobiesk, MD William Whitehead, MD Timothy Wiebe, MDEducational Conferences 2005 Online Cancer Staging Forms Shedding Light on Skin Cancer Overview of Cytotoxic Therapy inMetastatic Breast Cancer January 25, 2005 April 12, 2005 June 7, 2005 Diane Bailey, EPICS Rebecca Duff, MD Daniel Budman, MD Vertebroplasty Compression Fracture Radiofrequency Thermal Ablation Low Grade Secondary to Metastatic Disease Lymphoma July 12, 2005 August 16, 2005 October 11, 2005 Neil Solomon, MD Paul Shyn, MD John Hainsworth, MDCancer Committee 2006
Nagen Bellare, MD Joseph Salloum, MD Harry Butler, MD Mike Cheng, MD Tim Cole, MD Stephen L.Conerly, MD Co- Chair Co- Chair Medical Oncology Radiation Oncology Pathology Dermatology Medical Oncology Radiation Oncology Howell Crawford, MD James Duncan, MD Michael Hammett, MD Mark Molpus, MD Thomas Puckett, MD Todd Sitzman, MD Gastroenterology Surgery Otolaryngology Radiology Pathology Anesthesia/Pain Mgmt. Glenn Smith, MD John Sobiesk, MD Alphonso Willis, MD William Woods, MD Jennifer Easley Paula Hand Medical Oncology Otolaryngology Medical Oncology Radiation Oncology Dietician MedicalSocial Services Cancer Committee 2006 Linda Haywood Juliet Hinton, BSB, MBA, CTR Jena Hopkins Cherri Marshall, RN TammyMcBeth, RN Director, HIM Cancer Registry Cancer Registry Cancer Center CancerCenter Research Coordinator Allen Meadows Kristi Nesler Daphne Nix, BS, CTR Angela Pace Beth Peyton Administration Oncology Clinical Pharmacist Cancer Registry Quality Management Director, PCS Mary Ann Purvis Joyce Rogers, RN Barnard Shows Michelle Williams, RN LillieWillis
PCM Endoscopy/6T Radiation Oncology Radiation Oncology Clinical Specialist 6T AmericanCancer Society Footnotes: http://www.cancer.org/cancerfacts&figures2006 http://www.cbtrus.org/2004-2005/2004-2005.html Central Brain Tumor Registry of the United States. http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=3 American Cancer Society. http://en.wikipedia.org/wiki/Glioblastoma_multiforme. Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M, Belanger K, Brandes A, Marosi C, Bogdahn U, Curschmann J, Janzer R, Ludwin S, Gorlia T, Allgeier A, Lacombe D, Cairncross J, Eisenhauer E, Mirimanoff R (2005). "Radiotherapy plusconcomitant and adjuvant temozolomide for glioblastoma.". N Engl J Med 352 (10): 987-96.http://www.musictherapy.org/ American Music Therapy Association.http://stanleyjordan.com/Healing/musictherapyobser.html Stanley Jordan Website.http://www.cancerwise.org/april_2001.html Cancer Wise Website. “Music Therapy Aids Cancer Patients during Treatment.
Summary of American Cancer Society Recommendations for Early Detection of Cancer in Asymptomatic PeopleSite Recommendation Breast Women 40 and older should have an annual mammogram, an annual clinical breast examination (CBE) by a health care professional, and should perform monthly breast self-examination (BSE). Women ages 20-39 should have a CBE by a health care professional every three years and should perform BSE monthly.____________________________________________________________________________________________________________________________ Colon & Beginning at age 50, men and women should follow one of the Rectum examination schedules below: • A fecal occult blood (FOBT) test every year, or • A flexible sigmoidoscopy (FSIG) every five years, or • Annual fecal occult blood test and flexible sigmoidoscopy every five years. * • A double-contrast barium enema every five to 10 years. • A colonoscopy every 10 years. *Combined testing is preferred over either annual FOBT or FSIG every 5 years, alone. People who are at moderate or high risk for colorectal cancer should talk with a doctor about a different testing schedule.______________________________________________________________________________________________________ Prostate The PSA test and the digital rectal examination should be offered annually, beginning at age 50, to men who have a life expectancy of at least 10 years. Men at high risk (African-American men and men with a strong family history of one or more first-degree relatives diagnosed with prostate cancer at an early age) should begin testing at age 45. Information should be provided to patients about what is known and what is uncertain about the benefits and limitations of early detection and treatment of prostate cancer, so that they can make an informed decision.____________________________________________________________________________________________________________________ Uterus Cervix: All women who are or have been sexually active or who are 18 and older should have an annual Pap test and pelvicexamination. After
three or more consecutive satisfactory examinations with normal findings, the Pap test may be performed less frequently. Discuss the matter with your physician. Endometrium: The American Cancer Society recommends that all women should be informed about the risks and symptoms of endometrial cancer, and strongly encouraged to report any unexpected bleeding or spotting to their physicians. Annual screening for endometrial cancer with endometrial biopsy beginning at age 35 should be offered to women with or at risk for hereditary nonpolyposis colon cancer.____________________________________________________________________________________________________________________
Forrest General Hospital 6051 U. S. Highway 49 P. O. Box 16389 Hattiesburg, MS 39404-6389 Telephone: (601) 288-7000Toll Free Number: 1-800-844-4445Website: www.forrestgeneral.com